Publication for Pax3 and Tfap2b
| Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
|---|---|---|---|---|---|---|
| mmu | Pax3 | paired box 3 | 18505 | [link] | ||
| mmu | Tfap2b | transcription factor AP-2 beta | 21419 |
| Pubmed ID | Priority | Text |
|---|---|---|
| 18983540 | 0.98 | Pax3 or Pax3-FKHR corresponds to an increase of the anti-apoptotic genes BCL-XL and TFAP2B, further supporting the anti-apoptotic role of Pax3-FOXO1. |
| 24274149 | 0.98 | AP-2b) and Cdh3 (Placental P-cadherin), which have been identified as direct target genes of PAX3:FOXO1A in aRMS. |
| 30306639 | 0.98 | Pax3, Tfap2a, Tfap2b) that are expressed in early SC development were also induced at a low level. |
| 31566562 | 0.97 | Pax3, Tfap2b, Phox2b, Dbh, Crabp1, Neurog1 and Wnt3a, besides a suite of downregulated Hox genes (Hoxa2, Hoxa3, Hoxa4, Hoxa5, Hoxa9, Hoxb1, Hoxb2, Hoxb3, Hoxb4, Hoxb5, Hoxc4, Hoxc5, Hoxd3), which are prominently expressed during neural crest/pharyngeal arch patterning, where they control head skeletal development (Supplementary file 2). |
| 0.95 | Pax3, Hoxa2, Tfap2b and Neurog1) indicated mild neural and severe neural crest differentiation defects (Figure 6E and Figure 6:figure supplement 2). | |
| 19877281 | 0.97 | Pax3, Tcfap2b, Hes5 and Eya2, and the majority of the transcripts with the largest magnitude decreases could be assigned to one of these two classes. |
The preparation time of this page was 0.0 [sec].
